Ledger.Open graph →
SEC Form D · Amendment · filed November 18, 2022

SIRPant Immunotherapeutics, Inc

Offering
$27.3M
Sold
$13.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HUMMELSTOWN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

John Fucci · Hummelstown, PADirectorRifat C. Pamukcu · Hummelstown, PADirectorRobert C. Towarnicki · Hummelstown, PAExec · DirectorThomas J. Nedeau · New York, NYExec · DirectorDinyar G. Mistry · Nashville, TNDirectorMishthi G. Hanson · Nashville, TNDirectorTravis Whitfill · Farmington, CTDirectorJeffrey Wakeman · Cornelius, NCDirectorVanessa A. Anton · Fairlawn, OHDirectorJohn S. Nebesky · Fairlawn, OHExec · DirectorTravis Whitfill · Farmington, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗